|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
|
|---|---|---|---|
| Current assets | |||
| Cash and cash equivalents | |||
| Prepaid expenses | |||
| Total current assets | |||
| Deferred offering costs | |||
| Long-term prepaid insurance | |||
| Marketable securities held in Trust Account | |||
| Total Assets | |||
| Accrued expenses | |||
| Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit | |||
| Current liabilities | |||
| Accrued offering costs | |||
| Accrued expenses | |||
| Promissory note - related party | |||
| Related Party | |||
| Total promissory note - related party | |||
| Total current liabilities | |||
| Deferred underwriting fee | |||
| Total Liabilities | |||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 25,300,000 shares at redemption value of $10.15 per share as of June 30, 2026 and no shares as of December 31, 2025 | |||
| Class A Ordinary Shares | |||
| Total class A ordinary shares subject to possible redemption, $0.0001 par value; 25,300,000 shares at redemption value of $10.15 per share as of June 30, 2026 and no shares as of December 31, 2025 | |||
| Shareholders’ Deficit | |||
| Common stock, value | |||
| Class A Ordinary Shares | |||
| Class B Ordinary Shares | |||
| Additional paid-in capital | |||
| Accumulated deficit | |||
| Total Shareholders’ Deficit | |||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit |
Loading...
